Background and objectives Prior studies have shown that patients with oral cancer overexpress programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) in cancer cells and immunocompetent lymphocytes. This evidence concerns the gene PDCD1 and lip and oral cavity carcinoma.